IP Library › Granted Patent US 12,516,037
Granted Patent B2
US 12,516,037 · App. 18/591,732 · Granted Jan 6, 2026

Substituted thiophenecarboxamides and analogues as antibacterials agents

Inventors: David Bernier (Lyons, FR); Stéphane Brunet (Saint André de Corcy, FR); Jérémy Dufour (Lyons, FR); Thomas Knobloch (Charnay, FR); Lionel Nicolas (Lyons, FR); Tomoki Tsuchiya (Saint-Cyr-Au-Mont-d'Or, FR)
Assignee: Bayer Aktiengesellschaft
C07D333/38A01N43/10A01N43/76A01N55/00A01P1/00A01P13/00A61P31/04A61P33/00C07D409/12C07D413/04C07F7/0812C07F7/083
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,516,037
App. No.
18/591,732
Granted
Jan 6, 2026
Kind
B2
Abstract

The present disclosure relates to substituted thiophene carboxamides and analogues thereof that may be used for protecting plants from bacterial diseases, in particular from bacterial diseases caused by bacteria belonging to the genus Xanthomonas.

Claims (5)

1 . A compound of formula (VIIIa):

wherein

R 1 and R 2 are identical and are a chlorine atom or a bromine atom;

U 1a is a hydroxy group or a C 1 -C 6 -alkoxy group; and

U 2a is a mesylate group, a tosylate group or a triflate group.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2025
From: DUFOUR, JÉRÉMY; NICOLAS, LIONEL; TSUCHIYA, TOMOKI; KNOBLOCH, THOMAS; BRUNET, STÉPHANE; BERNIER, DAVID
To: BAYER S.A.S
Reel/Frame 073033/0064 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2025
From: BAYER S.A.S
To: BAYER AKTIENGESELLSCHAFT
Reel/Frame 073033/0178 →
Priority Claims (1)
EP 18181930 · Jul 5, 2018 · regional
Continuity (3)
Division 17810214 · Jun 30, 2022
Division 17256942
Related Publication 20240360098A1 · Oct 31, 2024
References Cited (71)
US 5245551A · Herron et al. · 1993 [cited by applicant]
US 5534541A · Drauz et al. · 1996 [cited by applicant]
US 6060051A · Heins et al. · 2000 [cited by applicant]
US 6245551B1 · Lehman et al. · 2001 [cited by applicant]
US 7094592B2 · Watanabe et al. · 2006 [cited by applicant]
US 11401254B2 · Bernier et al. · 2022 [cited by applicant]
US 11952359B2 · Bernier et al. · 2024 [cited by applicant]
US 20140213448A1 · Buysse et al. · 2014 [cited by applicant]
US 20140275503A1 · Giampietro et al. · 2014 [cited by applicant]
CN 101337937A · 2009 [cited by applicant]
CN 101337940A · 2009 [cited by applicant]
CN 101715774A · 2010 [cited by applicant]
CN 102391261A · 2012 [cited by applicant]
CN 103109816A · 2013 [cited by applicant]
CN 103232431A · 2013 [cited by applicant]
CN 103265527A · 2013 [cited by applicant]
CN 103524422A · 2014 [cited by applicant]
DE 3639877A1 · 1988 [cited by applicant]
EP 0450355A1 · 1991 [cited by applicant]
EP 2647626A1 · 2013 [cited by applicant]
JP 2010018586A · 2010 [cited by applicant]
WO WO03106457A1 · 2003 [cited by applicant]
WO WO2004024692A1 · 2004 [cited by examiner]
WO WO2004062361A2 · 2004 [cited by applicant]
WO WO2004099160A1 · 2004 [cited by applicant]
WO WO2006003494A2 · 2006 [cited by applicant]
WO WO2006003949A1 · 2006 [cited by applicant]
WO WO2006043635A1 · 2006 [cited by applicant]
WO WO2007003536A1 · 2007 [cited by applicant]
WO WO2007040280A1 · 2007 [cited by applicant]
WO WO2007040282A1 · 2007 [cited by applicant]
WO WO2007098356A1 · 2007 [cited by applicant]
WO WO2008109786A2 · 2008 [cited by applicant]
WO WO2009116106A1 · 2009 [cited by applicant]
WO WO2010051926A2 · 2010 [cited by applicant]
WO WO2010052161A2 · 2010 [cited by applicant]
WO WO2010066780A1 · 2010 [cited by applicant]
WO WO2011085575A1 · 2011 [cited by applicant]
WO WO2011105506A1 · 2011 [cited by applicant]
WO WO2011151146A1 · 2011 [cited by applicant]
WO WO2012029672A1 · 2012 [cited by applicant]
WO WO2012034403A1 · 2012 [cited by applicant]
WO WO2012054721A1 · 2012 [cited by applicant]
WO WO2012114285A1 · 2012 [cited by applicant]
WO WO2013050317A1 · 2013 [cited by applicant]
WO WO2013115391A1 · 2013 [cited by applicant]
WO WO2013144213A1 · 2013 [cited by applicant]
WO WO2013162715A2 · 2013 [cited by applicant]
WO WO2013162716A2 · 2013 [cited by applicant]
WO WO2014187846A1 · 2014 [cited by applicant]
WO WO2015058021A1 · 2015 [cited by applicant]
WO WO2015058028A1 · 2015 [cited by applicant]
WO WO2016005276A1 · 2016 [cited by applicant]
WO WO2016133011A1 · 2016 [cited by applicant]
WO WO2016154297A1 · 2016 [cited by applicant]
Belikov; V.G., “Pharmaceutical Chemistry”, 2007, p. 27-29. [cited by applicant]
Dyson; G. May P., “Chemistry of Synthetic Drugs”, 1964, p. 12-19. [cited by applicant]
Mashkovsky; Md, “Drugs”, 2001, 14th Edition vol. 1, 11. [cited by applicant]
Smith; et al., “Organic Synthesis”, Science and Art, 2001, p. 573, 64 and 159. [cited by applicant]
“A Publication of Ascensus Specialties: MOVCD, CVD; ALD Precursors”, Strem Catalog by Ascensus Specialties, Nov. 2018. [cited by applicant]
Crisma, Marco, “Electron Impact Mass Spectrometry of Some 2-(p-Bromophenyl)-4, 4-disubstituted-5(4H)-oxazolones”, Journal of Heterocyclic Chemistry, Jan.-Feb. 1988, p. 209-215, vol. 25. No. 1. [cited by applicant]
Fujimoto, T. et al., “PhenoFluor: Practical Synthesis, New Formulation, and Deoxyfluorination of Heteroaromatics”, Organic Process Research; Development, Dec. 2014, pp. 1041-1044, vol. 18. [cited by applicant]
Kalvet, I, et al., “Palladium(I) Dimer Enabled Extremely Rapid and Chemoselective Alkylation of Aryl Bromides oven Triflates and Chlorides in Air” Angewandte Chemier Intemational Edition, 2017, pp. 7078-7082, vol. 56. [cited by applicant]
Tang P. et “Deoxyfluorination of Phenols”, Journal of American Chemistry Society, 2011, pp. 11482-11484, vol. 133. [cited by applicant]
Kalvet, I, et al., 'Rapid Room-Temperature, Chemoselective Csp2-Csp2 Coupling of Poly(pseudo)halogenated renes Enabled by Palladium(I) Catalysis in Air, Angewandte Chemier Intemational Edition, 2017, pp. 1581-1581, vol.… [cited by applicant]
Mo, et al., “Renaissance of Sandmeyer-Type Reactions- Conversion of Aromatic C-N Bonds into C-X Bonds (X n, P, or CF3)”, Accounts of Chemical Research, 2018, pp. 496-506, vol. 51. [cited by applicant]
Ongena, M. et al., “Bacillus lipopeptides: versatile weapons for plant disease biocontrol”, Trends in Microbiology, Mar. 2008, pp. 115-125, vol. 16- No. 3. [cited by applicant]
“Phosphorus Ligands and Compounds Brochure”, Strem Chemicals, 2017. [cited by applicant]
Schank, K., “Chapter 14: Preparation of diazonium groups” from The Chemistry of Diazonium and Diazo Groups, 1978, p. 645-657. [cited by applicant]
Wulfman, D. S., “Chapter 8: Synthetic Applications of diazonium ions” from The Chemistry of Diazonium and Diazo Groups, 1978, pp. 288-290. [cited by applicant]
Wuts, Peter G. M., “Greene's Protective Groups in Organic Synthesis”, Fifth Edition, 2014, pp. 895-1193. [cited by applicant]